Elinzanetant (NT-814): a novel, non-hormonal dual NK-1,3 receptor antagonist for the treatment of vasomotor symptoms - key findings from the Phase 2 SWITCH-1 studyNicholas Panay,Richard A Anderson,Hadine Joffe,Cecilia Caetano,Steve Pawsey,Christian Seitz,Lineke Zuurman,James SimonMaturitas(2021)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要